{
  "verifiedOn": "2026-11-07",
  "compound": "Retatrutide peptide",
  "slug": "retatrutide",
  "products": [
    {
      "ingredientIdentity": "Retatrutide (LY3437943), a single peptide acting at GIP, GLP-1 and glucagon receptors",
      "casNumber": "2381089-83-2",
      "formula": "C221H342N46O68",
      "theoreticalMolecularMassDa": 4731.4,
      "counterIon": null,
      "unitCount": 1,
      "price": null,
      "checkoutUrl": null,
      "availability": null,
      "additionalAccessories": null,
      "intendedUse": "Laboratory research material; not a finished approved medicine.",
      "id": "vial-30mg",
      "formatKind": "vial",
      "title": "Retatrutide 30 mg vial",
      "shortName": "30 mg vial",
      "format": "Freeze-dried peptide powder",
      "totalMg": 30,
      "amountLabel": "30 mg retatrutide per vial",
      "ingredientAmountsMg": {
        "Retatrutide": 30
      },
      "ingredients": [
        "Retatrutide"
      ],
      "concentrationMgMl": null,
      "fillVolumeMl": null,
      "containerVolumeMl": 3,
      "containerVolumeBasis": "The product image identifies a 3 mL vial. This is container size, not a final mixed volume or a claim that liquid is supplied.",
      "unitName": "vial",
      "perUnitMcg": 30000,
      "photoFile": "retatrutide-30mg-vial-unbranded.png",
      "photoAlt": "Retatrutide 30 mg vial, product photograph with supplier branding removed",
      "photoWidth": 1254,
      "photoHeight": 1254,
      "preparation": "Powder requires preparation to a known final volume; concentration is not set by the vial size.",
      "mixingRequired": true,
      "preparationDiluent": null,
      "preparationDiluentVolumeMl": null,
      "preparationHandling": "Allow the sealed vial to reach room temperature before opening to avoid condensation. Add method-specified diluent slowly to the vial wall; do not shake.",
      "appearance": "White to off-white lyophilized powder or cake",
      "storage": "Sealed powder: −20°C (−4°F), dry and protected from light. Prepared solution: 2–8°C (36–46°F), light protected, within its validated preparation period.",
      "storageTemperatureC": [
        -20
      ],
      "storageTemperatureF": [
        -4
      ],
      "preparedStorageTemperatureC": [
        2,
        8
      ],
      "preparedStorageTemperatureF": [
        35.6,
        46.4
      ],
      "inUseLimit": null,
      "lot": "PL-2609-084",
      "coaId": "retatrutide-30mg",
      "coaFile": "retatrutide-30mg-lot-pl-2609-084-coa-redacted.pdf",
      "coaLotLinkageConfirmed": true,
      "displayCoaLabel": "Redacted 30 mg vial COA",
      "coaCoverage": "3 sampled powder vials from lot PL-2609-084",
      "coaScope": "Powder lot PL-2609-084: 99.38% HPLC area purity. No separate mg-per-vial content assay.",
      "keyDifference": "Half the labelled amount of the 60 mg vial and twice the 15 mg pen total.",
      "measurement": "Concentration = labelled vial milligrams divided by final solution millilitres.",
      "packageContents": [
        "One sealed glass vial with rubber stopper and aluminium crimp"
      ],
      "specificationBasis": "Product specifications and safety data sheet PL-SDS-140, revision 1.0 dated 3 October 2026; product image confirms nominal 3 mL vial size.",
      "labelAmountVsAssay": "30 mg is the label claim. The attached certificate reports purity and identity, not an independent quantitative fill-content assay.",
      "displayAmount": "30",
      "displayUnit": "mg retatrutide per vial",
      "description": "30 mg of single-ingredient powder with its own redacted lot report.",
      "specs": [
        [
          "Contents",
          "30 mg · 30,000 mcg"
        ],
        [
          "Form",
          "Freeze-dried powder"
        ],
        [
          "Preparation",
          "Mixing required"
        ],
        [
          "Sealed storage",
          "−20°C (−4°F) · dry and dark"
        ]
      ],
      "buyLabel": "Buy Retatrutide 30 mg vial",
      "photoEdited": true,
      "photoEditNote": "Supplier branding removed from the supplied photograph; key product labels retained."
    },
    {
      "ingredientIdentity": "Retatrutide (LY3437943), a single peptide acting at GIP, GLP-1 and glucagon receptors",
      "casNumber": "2381089-83-2",
      "formula": "C221H342N46O68",
      "theoreticalMolecularMassDa": 4731.4,
      "counterIon": null,
      "unitCount": 1,
      "price": null,
      "checkoutUrl": null,
      "availability": null,
      "additionalAccessories": null,
      "intendedUse": "Laboratory research material; not a finished approved medicine.",
      "id": "vial-60mg",
      "formatKind": "vial",
      "title": "Retatrutide 60 mg vial",
      "shortName": "60 mg vial",
      "format": "Freeze-dried peptide powder",
      "totalMg": 60,
      "amountLabel": "60 mg retatrutide per vial",
      "ingredientAmountsMg": {
        "Retatrutide": 60
      },
      "ingredients": [
        "Retatrutide"
      ],
      "concentrationMgMl": null,
      "fillVolumeMl": null,
      "containerVolumeMl": 3,
      "containerVolumeBasis": "The product image identifies a 3 mL vial. This is container size, not a final mixed volume or a claim that liquid is supplied.",
      "unitName": "vial",
      "perUnitMcg": 60000,
      "photoFile": "retatrutide-60mg-vial-unbranded.png",
      "photoAlt": "Retatrutide 60 mg vial, product photograph with supplier branding removed",
      "photoWidth": 1254,
      "photoHeight": 1254,
      "preparation": "Powder requires preparation to a known final volume; concentration is not set by the vial size.",
      "mixingRequired": true,
      "preparationDiluent": null,
      "preparationDiluentVolumeMl": null,
      "preparationHandling": "Allow the sealed vial to reach room temperature before opening to avoid condensation. Add method-specified diluent slowly to the vial wall; do not shake.",
      "appearance": "White to off-white lyophilized powder or cake",
      "storage": "Sealed powder: −20°C (−4°F), dry and protected from light. Prepared solution: 2–8°C (36–46°F), light protected, within its validated preparation period.",
      "storageTemperatureC": [
        -20
      ],
      "storageTemperatureF": [
        -4
      ],
      "preparedStorageTemperatureC": [
        2,
        8
      ],
      "preparedStorageTemperatureF": [
        35.6,
        46.4
      ],
      "inUseLimit": null,
      "lot": "PL-2609-087",
      "coaId": "retatrutide-60mg",
      "coaFile": "retatrutide-60mg-lot-pl-2609-087-coa-redacted.pdf",
      "coaLotLinkageConfirmed": true,
      "displayCoaLabel": "Redacted 60 mg vial COA",
      "coaCoverage": "2 sampled powder vials from lot PL-2609-087",
      "coaScope": "Powder lot PL-2609-087: 99.27% HPLC area purity. No separate mg-per-vial content assay.",
      "keyDifference": "Twice the labelled amount of the 30 mg vial and four times the 15 mg pen total.",
      "measurement": "Concentration = labelled vial milligrams divided by final solution millilitres.",
      "packageContents": [
        "One sealed glass vial with rubber stopper and aluminium crimp"
      ],
      "specificationBasis": "Product specifications and safety data sheet PL-SDS-140, revision 1.0 dated 3 October 2026; product image confirms nominal 3 mL vial size.",
      "labelAmountVsAssay": "60 mg is the label claim. The attached certificate reports purity and identity, not an independent quantitative fill-content assay.",
      "displayAmount": "60",
      "displayUnit": "mg retatrutide per vial",
      "description": "60 mg of single-ingredient powder with its own matching product image and lot report.",
      "specs": [
        [
          "Contents",
          "60 mg · 60,000 mcg"
        ],
        [
          "Form",
          "Freeze-dried powder"
        ],
        [
          "Preparation",
          "Mixing required"
        ],
        [
          "Sealed storage",
          "−20°C (−4°F) · dry and dark"
        ]
      ],
      "buyLabel": "Buy Retatrutide 60 mg vial",
      "photoEdited": true,
      "photoEditNote": "Supplier branding removed from the supplied photograph; key product labels retained."
    },
    {
      "ingredientIdentity": "Retatrutide (LY3437943), a single peptide acting at GIP, GLP-1 and glucagon receptors",
      "casNumber": "2381089-83-2",
      "formula": "C221H342N46O68",
      "theoreticalMolecularMassDa": 4731.4,
      "counterIon": null,
      "unitCount": 1,
      "price": null,
      "checkoutUrl": null,
      "availability": null,
      "additionalAccessories": null,
      "intendedUse": "Laboratory research material; not a finished approved medicine.",
      "id": "pen",
      "formatKind": "pen",
      "title": "Retatrutide 15 mg prefilled pen",
      "shortName": "15 mg pen",
      "format": "Prepared solution in a 3 mL pen",
      "totalMg": 15,
      "amountLabel": "15 mg retatrutide total · 3 mL · 5 mg/mL",
      "totalAmountBasis": "The product specifies 15 mg per 3 mL; 3 mL × 5 mg/mL.",
      "ingredientAmountsMg": {
        "Retatrutide": 15
      },
      "ingredientConcentrationsMgMl": {
        "Retatrutide": 5
      },
      "concentrationMgMl": 5,
      "fillVolumeMl": 3,
      "percentWeightVolume": 0.5,
      "unitName": "pen",
      "perUnitMcg": 15000,
      "perClickMl": null,
      "perClickMcg": null,
      "deviceScale": null,
      "photoFile": "retatrutide-15mg-pen-unbranded.png",
      "photoAlt": "Retatrutide 15 mg prefilled pen, product photograph with supplier branding removed",
      "photoWidth": 1254,
      "photoHeight": 1254,
      "preparation": "Already dissolved at 5 mg/mL. No water is added to the cartridge.",
      "mixingRequired": false,
      "ingredients": [
        "Retatrutide",
        "Water",
        "Benzyl alcohol 0.9% w/v"
      ],
      "excipients": [
        {
          "ingredient": "Water",
          "amount": "Balance of solution"
        },
        {
          "ingredient": "Benzyl alcohol",
          "percentWeightVolume": 0.9
        }
      ],
      "appearance": "Clear, colourless to faint-yellow aqueous solution",
      "storage": "2–8°C (36–46°F), capped in the original carton and protected from light. Do not freeze.",
      "storageTemperatureC": [
        2,
        8
      ],
      "storageTemperatureF": [
        35.6,
        46.4
      ],
      "discardConditions": "Discard if frozen, cloudy or discoloured.",
      "inUseLimit": null,
      "lot": null,
      "coaId": null,
      "coaFile": null,
      "coaLotLinkageConfirmed": false,
      "displayCoaLabel": "Finished-pen COA not supplied",
      "coaCoverage": "No finished-pen report or documented connection to either supplied powder lot.",
      "coaScope": "The two attached certificates cover powder vials. Neither verifies this pen batch or its finished solution.",
      "keyDifference": "15 mg total: half a 30 mg vial or one quarter of a 60 mg vial; fixed 5 mg/mL concentration.",
      "measurement": "Liquid volume can be calculated from 5 mg/mL. Mechanical click size and dial calibration are unconfirmed.",
      "packageContents": [
        "One prefilled 3 mL glass cartridge in an autoinjector pen"
      ],
      "extraNeedleCount": null,
      "specificationBasis": "Product specifications and safety data sheet PL-SDS-141, revision 1.0 dated 3 October 2026. No device-specific delivery calibration supplied.",
      "labelAmountVsAssay": "15 mg is the stated total; no finished-cartridge quantitative content assay supplied.",
      "displayAmount": "15",
      "displayUnit": "mg retatrutide per pen",
      "description": "3 mL of prepared solution at 5 mg/mL. No powder-mixing step.",
      "specs": [
        [
          "Cartridge",
          "3 mL · 5 mg/mL"
        ],
        [
          "Solution",
          "Water + 0.9% benzyl alcohol"
        ],
        [
          "Preparation",
          "Already mixed"
        ],
        [
          "Storage",
          "2–8°C (36–46°F) · do not freeze"
        ]
      ],
      "buyLabel": "Buy Retatrutide 15 mg prefilled pen",
      "photoEdited": true,
      "photoEditNote": "Supplier branding removed from the supplied photograph; key product labels retained."
    }
  ],
  "coas": [
    {
      "id": "retatrutide-30mg",
      "productId": "vial-30mg",
      "displayForProductIds": [
        "vial-30mg"
      ],
      "title": "Retatrutide 30 mg — lot PL-2609-084",
      "file": "retatrutide-30mg-lot-pl-2609-084-coa-redacted.pdf",
      "preview": "retatrutide-30mg-lot-pl-2609-084-coa-redacted-page-1.png",
      "pageCount": 2,
      "lot": "PL-2609-084",
      "certificateNumber": "PL-26-00084",
      "labelClaim": "30 mg retatrutide per vial",
      "sampleDescription": "Lyophilized powder",
      "purityPercent": 99.38,
      "purityLabel": "HPLC area purity",
      "purityMethod": "RP-HPLC, UV 214 nm; main peak area divided by total integrated area",
      "mainPeakRetentionTimeMin": 8.72,
      "printedMainPeakArea": 4702407,
      "printedTotalPeakArea": 4731744,
      "calculatedPurityFromPrintedAreasPercent": 99.37999604374201,
      "printedAreaPercentTotal": 100.0,
      "reportConsistencyStatus": "Printed peak areas and percentages reconcile to the stated result at two decimal places.",
      "peakTable": [
        {
          "rt": 6.09,
          "area": 5678,
          "percent": 0.12
        },
        {
          "rt": 7.54,
          "area": 9937,
          "percent": 0.21
        },
        {
          "rt": 8.26,
          "area": 7098,
          "percent": 0.15
        },
        {
          "rt": 8.72,
          "area": 4702407,
          "percent": 99.38
        },
        {
          "rt": 9.08,
          "area": 6624,
          "percent": 0.14
        }
      ],
      "largestImpurityPercent": 0.21,
      "largestImpurityRetentionTimeMin": 7.54,
      "largestImpurityIdentity": "Gln3/Gln19 deamidation, as reported",
      "identityMassDa": {
        "Retatrutide": 4731.7
      },
      "theoreticalMassDa": {
        "Retatrutide": 4731.4
      },
      "identityMethod": "LC-MS, positive electrospray ionization; stated mass acceptance ±1.0 Da",
      "formula": "C221H342N46O68",
      "casNumber": "2381089-83-2",
      "waterPercent": 1.8,
      "waterMethod": "Karl Fischer",
      "endotoxinEUPerMg": 0.08,
      "endotoxinSpecificationEUPerMg": "≤5.0",
      "endotoxinMethod": "Kinetic LAL",
      "sterilityResult": "No growth; conforms",
      "sterilityMethod": "USP <71>, membrane filtration; no growth after 14 days",
      "contentAssay": null,
      "contentAssayNote": "No quantitative fill-content result is listed. 30 mg is the vial label claim.",
      "analysisDate": "2026-09-19",
      "waterTestDate": "2026-09-19",
      "endotoxinTestDate": "2026-09-19",
      "sterilityTestDate": "2026-09-19",
      "manufacturedDate": "2026-09-18",
      "issueDate": "2026-10-03",
      "retestExpiry": "2028-09-18",
      "unitsInLot": 300,
      "unitsSampled": 3,
      "storage": "−20°C (−4°F), desiccated and protected from light.",
      "laboratoryType": "In-house",
      "outsideReportsAttached": "None",
      "conclusion": "PASS stated in the source report.",
      "scope": "3 sampled powder vials from lot PL-2609-084; in-house testing. No separate quantitative vial-fill assay or finished-pen testing.",
      "sha256": "da77ca3d842bfaebccc450b41fd6bdacb6d6a4c3d14f3eb1048e43be81a9f29f",
      "facts": [
        [
          "Label claim",
          "30 mg per powder vial"
        ],
        [
          "LC-MS identity",
          "4731.7 Da"
        ],
        [
          "Endotoxin",
          "0.08 EU/mg"
        ],
        [
          "Sterility",
          "No growth after 14 days"
        ],
        [
          "Analysis date",
          "19 September 2026"
        ],
        [
          "Sampled units",
          "3 of 300"
        ]
      ],
      "documentTreatment": "Redacted copy: supplier identifiers removed; analytical values, lot, dates and in-house status retained."
    },
    {
      "id": "retatrutide-60mg",
      "productId": "vial-60mg",
      "displayForProductIds": [
        "vial-60mg"
      ],
      "title": "Retatrutide 60 mg — lot PL-2609-087",
      "file": "retatrutide-60mg-lot-pl-2609-087-coa-redacted.pdf",
      "preview": "retatrutide-60mg-lot-pl-2609-087-coa-redacted-page-1.png",
      "pageCount": 2,
      "lot": "PL-2609-087",
      "certificateNumber": "PL-26-00087",
      "labelClaim": "60 mg retatrutide per vial",
      "sampleDescription": "Lyophilized powder",
      "purityPercent": 99.27,
      "purityLabel": "HPLC area purity",
      "purityMethod": "RP-HPLC, UV 214 nm; main peak area divided by total integrated area",
      "mainPeakRetentionTimeMin": 8.87,
      "printedMainPeakArea": 4697467,
      "printedTotalPeakArea": 4732010,
      "calculatedPurityFromPrintedAreasPercent": 99.2700142222861,
      "printedAreaPercentTotal": 100.0,
      "reportConsistencyStatus": "Printed peak areas and percentages reconcile to the stated result at two decimal places.",
      "peakTable": [
        {
          "rt": 6.21,
          "area": 5678,
          "percent": 0.12
        },
        {
          "rt": 7.68,
          "area": 12303,
          "percent": 0.26
        },
        {
          "rt": 8.41,
          "area": 8991,
          "percent": 0.19
        },
        {
          "rt": 8.87,
          "area": 4697467,
          "percent": 99.27
        },
        {
          "rt": 9.22,
          "area": 7571,
          "percent": 0.16
        }
      ],
      "largestImpurityPercent": 0.26,
      "largestImpurityRetentionTimeMin": 7.68,
      "largestImpurityIdentity": "Gln3/Gln19 deamidation, as reported",
      "identityMassDa": {
        "Retatrutide": 4731.6
      },
      "theoreticalMassDa": {
        "Retatrutide": 4731.4
      },
      "identityMethod": "LC-MS, positive electrospray ionization; stated mass acceptance ±1.0 Da",
      "formula": "C221H342N46O68",
      "casNumber": "2381089-83-2",
      "waterPercent": 1.9,
      "waterMethod": "Karl Fischer",
      "endotoxinEUPerMg": 0.06,
      "endotoxinSpecificationEUPerMg": "≤5.0",
      "endotoxinMethod": "Kinetic LAL",
      "sterilityResult": "No growth; conforms",
      "sterilityMethod": "USP <71>, membrane filtration; no growth after 14 days",
      "contentAssay": null,
      "contentAssayNote": "No quantitative fill-content result is listed. 60 mg is the vial label claim.",
      "analysisDate": "2026-09-19",
      "waterTestDate": "2026-09-19",
      "endotoxinTestDate": "2026-09-19",
      "sterilityTestDate": "2026-09-19",
      "manufacturedDate": "2026-09-18",
      "issueDate": "2026-10-03",
      "retestExpiry": "2028-09-18",
      "unitsInLot": 150,
      "unitsSampled": 2,
      "storage": "−20°C (−4°F), desiccated and protected from light.",
      "laboratoryType": "In-house",
      "outsideReportsAttached": "None",
      "conclusion": "PASS stated in the source report.",
      "scope": "2 sampled powder vials from lot PL-2609-087; in-house testing. No separate quantitative vial-fill assay or finished-pen testing.",
      "sha256": "50ce51734629e7543f67f4de3aa7f33e58cb388bc9849a925ea23c4094e2c39a",
      "facts": [
        [
          "Label claim",
          "60 mg per powder vial"
        ],
        [
          "LC-MS identity",
          "4731.6 Da"
        ],
        [
          "Endotoxin",
          "0.06 EU/mg"
        ],
        [
          "Sterility",
          "No growth after 14 days"
        ],
        [
          "Analysis date",
          "19 September 2026"
        ],
        [
          "Sampled units",
          "2 of 150"
        ]
      ],
      "documentTreatment": "Redacted copy: supplier identifiers removed; analytical values, lot, dates and in-house status retained."
    }
  ],
  "unresolvedFacts": [
    "Customer selling prices, stock, checkout destinations and accessory counts",
    "Product-specific pen marked-unit and mechanical-click calibration",
    "Pen batch and its linkage to either supplied powder lot",
    "Finished-pen quantitative content, sterility and stability results",
    "Quantitative vial-content assay and lot-specific salt counterion",
    "Validated powder-preparation diluent, final mixing volume and in-use limits"
  ]
}